Skip to main content

Lacrisert

Generic: hydroxypropyl cellulose

Verified·Apr 23, 2026
Manufacturer
Bausch and Lomb
NDC
24208-800
RxCUI
476707
Route
OPHTHALMIC
ICD-10 indication
H16.229

Affordability Check

How much will you actually pay for Lacrisert?

In 30 seconds, see every legitimate way to afford Lacrisert — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Lacrisert

What is this medication? Lacrisert is a prescription ophthalmic insert used to treat moderate to severe dry eye syndromes, such as keratoconjunctivitis sicca. It is a small, sterile, rod-shaped insert made of hydroxypropyl cellulose, which acts as a lubricant. This medication is typically recommended for patients who do not find sufficient relief from traditional artificial tear solutions or for those with specific conditions like Sjogrens syndrome, exposure keratitis, or decreased corneal sensitivity.

The insert is placed into the pocket of the lower eyelid, where it slowly dissolves over the course of the day. As it melts, it releases a substance that thickens and stabilizes the natural tear film, providing long-lasting lubrication and reducing symptoms like burning, itching, and the sensation of having a foreign object in the eye. By prolonging tear film breakup time, it helps protect the surface of the eye from irritation and damage caused by excessive dryness.

Copay & patient assistance

  • Patient Copay Amount: As little as $0 for XIIDRA and MIEBO; as little as $35 for other portfolio brands ($25 at Walgreens and participating independent pharmacies). Patients whose insurance does not cover the product may pay $79 per 30-day supply if a Prior Authorization is submitted and denied.
  • Maximum Annual Benefit Limit: Program is limited to 12 fills per 12-month period for XIIDRA, MIEBO, VYZULTA, and TIMOPTIC in OCUDOSE; all other brands are limited to 6 fills per 12-month period. Specific annual dollar maximum is Not Publicly Available.
  • Core Eligibility Restrictions: Offer valid only for patients with commercial insurance; not valid for patients covered by Medicare, Medicaid, TRICARE, Veterans Affairs, or any other federal or state healthcare program; must be at least 18 years of age; not valid in California or Massachusetts for any product with a therapeutically equivalent generic available.
  • RxBIN, PCN, and Group numbers: Not Publicly Available.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.